Tesla
TSLA
NVIDIA
NVDA
Advanced Micro Devices
AMD
Taiwan Semiconductor
TSM
Qualcomm
QCOM
US Stock MarketDetailed Quotes
VIRX Viracta Therapeutics
- 0.223
- +0.046+26.06%
Close Jan 3 16:00 ET
- 0.205
- -0.018-7.89%
Post 19:57 ET
8.86MMarket Cap-0.20P/E (TTM)
0.225High0.170Low10.92MVolume0.175Open0.177Pre Close2.19MTurnover38.06%Turnover RatioLossP/E (Static)39.74MShares1.31052wk High-1.34P/B6.40MFloat Cap0.13252wk Low--Dividend TTM28.69MShs Float9324.000Historical High--Div YieldTTM30.98%Amplitude0.132Historical Low0.200Avg Price1Lot Size
Viracta Therapeutics News
Viracta Therapeutics | 8-K: Current report
Viracta Therapeutics | 8-K: Current report
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Viracta Therapeutics | 8-K: Current report
Viracta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Viracta Therapeutics | 10-Q: Q3 2024 Earnings Report
Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Viracta Therapeutics | 8-K: Current report
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Viracta Therapeutics | 10-Q: Q2 2024 Earnings Report
Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Viracta Therapeutics | 8-K: Current report
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Borellini Flavia
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chung Jane
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Murphy Samuel Lafayette
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DARCY THOMAS E
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simon Barry J.
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
